This week CDC discusses vaccine recommendations; a provider offers insights on administering live biotherapeutics; and early administration of simnotrelvir plus ritonavir shortened the time to sustained resolution of COVID-19 symptoms.
Gyre Therapeutics' Hydronidone Meets Primary Endpoint in Phase 3 Hepatitis B Trial
World Hepatitis Day: Where Do We Go From Here?
Hepatitis A Outbreak Declared in Los Angeles County
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Hepatitis E Vaccine Demonstrates High Efficacy in Outbreak Setting
Top 5 Infectious Disease News Stories Week of April 19-26